Your browser doesn't support javascript.
loading
AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor.
Ingle, Komala; LaComb, Joseph F; Graves, Lee M; Baines, Antonio T; Bialkowska, Agnieszka B.
Afiliación
  • Ingle K; Department of Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States of America.
  • LaComb JF; Department of Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States of America.
  • Graves LM; Department of Pharmacology, School of Medicine, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Baines AT; Department of Pharmacology, School of Medicine, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Bialkowska AB; Department of Biological & Biomedical Sciences, College of Health & Sciences, North Carolina Central University, Durham, North Carolina, United States of America.
PLoS One ; 18(11): e0294065, 2023.
Article en En | MEDLINE | ID: mdl-37943821
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Antineoplásicos Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Antineoplásicos Límite: Humans Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos